NuCana (NCNA) Interest Income - Total (2017 - 2025)
NuCana (NCNA) reported Interest Income - Total of -$230118.8 for Q4 2025, down 139.05% on a YoY basis from $589246.9 in Q4 2024, and down 11.46% sequentially from -$206452.4 in Q3 2025.
NuCana (NCNA) Interest Income - Total (2017 - 2025) Analysis & Trends
NuCana (NCNA) has 9 years of Interest Income - Total data on file, last reported at -$230118.8 in Q4 2025.
- For the quarter ending Q4 2025, Interest Income - Total fell 139.05% year-over-year to -$230118.8; the trailing twelve-month figure through Dec 2025 stood at -$626383.4 (down 37.08% YoY), and the FY2025 full-year result was -$508945.0, down 11.22% from the prior year.
- Interest Income - Total slipped to -$230118.8 in Q4 2025, from -$206452.4 in the prior quarter.
- In the past five years, Interest Income - Total ranged from a high of -$29656.2 in Q4 2021 to a low of -$348851.2 in Q1 2023.
- A 5-year average of -$136098.9 and a median of -$133561.0 in 2024 frame the typical range for Interest Income - Total.
- Across the five-year window, Interest Income - Total soared 82.07% in 2021 and tumbled 712.44% in 2023, its largest moves.
- Tracing NCNA's Interest Income - Total over 5 years: stood at -$29656.2 in 2021, then tumbled by 456.27% to -$164970.2 in 2022, then dropped by 3.07% to -$170037.8 in 2023, then soared by 43.39% to -$96262.6 in 2024, then sank by 139.05% to -$230118.8 in 2025.
- Business Quant data shows NCNA's Interest Income - Total at -$230118.8 in Q4 2025, -$206452.4 in Q3 2025, and -$96262.6 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Total (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -230,118.75 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -230,118.75 |
| Dec 31, 2025 | -230,118.75 |
| Sep 30, 2025 | -206,452.41 |
| Sep 30, 2025 | -206,452.41 |
| Dec 31, 2024 | -96,262.64 |
| Dec 31, 2024 | -96,262.64 |
| Sep 30, 2024 | -93,549.61 |
| Sep 30, 2024 | -93,549.61 |
| Jun 30, 2024 | -107,288.76 |
| Jun 30, 2024 | -107,288.76 |
| Mar 31, 2024 | -159,833.29 |
| Mar 31, 2024 | -159,833.29 |
| Dec 31, 2023 | -170,037.81 |
| Dec 31, 2023 | -170,037.81 |
| Sep 30, 2023 | -192,536.09 |
| Sep 30, 2023 | -192,536.09 |
| Jun 30, 2023 | -222,742.64 |
| Jun 30, 2023 | -222,742.64 |
| Mar 31, 2023 | -348,851.23 |
| Mar 31, 2023 | -348,851.23 |